Role of PET-CT in the Prediction of Response to Neoadjuvant Treatment
作者： David Fuster , Maria Cristina Marzola , Francesca Pons , Giovanni de Manzoni , Domenico Rubello
DOI: 10.1007/978-88-470-2330-7_6
关键词:
摘要: Even if surgery is still the main therapeutic option in patients with esophageal squamous cell carcinoma (SCC), recent studies have shown that neoadjuvant chemoradiotherapy (CRT) can reduce incidence of local recurrence and improve overall survival rate [1, 2, 3].
springer.com
sci-hub.st 参考文章(17)
Wolfgang A. Weber, Katja Ott, Karen Becker, Hans-Joachim Dittler, Hermann Helmberger, Norbert E. Avril, Günther Meisetschläger, Raymonde Busch, Jörg-Rüdiger Siewert, Markus Schwaiger, Ulrich Fink, Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging Journal of Clinical Oncology. ,vol. 19, pp. 3058- 3065 ,(2001) , 10.1200/JCO.2001.19.12.3058
Marinke Westerterp, Henderik L. van Westreenen, Johannes B. Reitsma, Otto S. Hoekstra, Jaap Stoker, Paul Fockens, Pieter L. Jager, Berthe L. F. Van Eck-Smit, John T. M. Plukker, J. Jan B. van Lanschot, Gerrit W. Sloof, Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy. Systematic review Radiology. ,vol. 236, pp. 841- 851 ,(2005) , 10.1148/RADIOL.2363041042
Ángel C. Rebollo Aguirre, Carlos Ramos-Font, Román Villegas Portero, Gary J. R. Cook, José M. Llamas Elvira, Antonio Romero Tabares, 18F-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer: systematic review of the literature. Annals of Surgery. ,vol. 250, pp. 247- 254 ,(2009) , 10.1097/SLA.0B013E3181B0C3A6
Florian Lordick, Katja Ott, Bernd-Joachim Krause, Wolfgang A Weber, Karen Becker, Hubert J Stein, Sylvie Lorenzen, Tibor Schuster, Hinrich Wieder, Ken Herrmann, Rainer Bredenkamp, Heinz Höfler, Ulrich Fink, Christian Peschel, Markus Schwaiger, Jörg R Siewert, PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncology. ,vol. 8, pp. 797- 805 ,(2007) , 10.1016/S1470-2045(07)70244-9
David R. Jones, Leonard A. Parker, Frank C. Detterbeck, Thomas M. Egan, Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer. ,vol. 85, pp. 1026- 1032 ,(1999) , 10.1002/(SICI)1097-0142(19990301)85:5<1026::AID-CNCR3>3.0.CO;2-N
D. Vallböhmer, A.H. Hölscher, P.M. Schneider, M. Schmidt, M. Dietlein, E. Bollschweiler, S. Baldus, H. Alakus, J. Brabender, R. Metzger, S. P. Mönig, [18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. Journal of Surgical Oncology. ,vol. 102, pp. 135- 140 ,(2010) , 10.1002/JSO.21592
Peter D Siersema, Pathogenesis, diagnosis and therapeutic possibilities of esophageal cancer. Current Opinion in Gastroenterology. ,vol. 23, pp. 456- 461 ,(2007) , 10.1097/MOG.0B013E32816A91DE
B. J. Krause, K. Herrmann, H. Wieder, C. M. zum Buschenfelde, 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer The Journal of Nuclear Medicine. ,vol. 50, ,(2009) , 10.2967/JNUMED.108.057232
Johannes B. Roedl, Mukesh G. Harisinghani, Rivka R. Colen, Alan J. Fischman, Michael A. Blake, Douglas J. Mathisen, Peter R. Mueller, Assessment of Treatment Response and Recurrence in Esophageal Carcinoma Based on Tumor Length and Standardized Uptake Value on Positron Emission Tomography–Computed Tomography The Annals of Thoracic Surgery. ,vol. 86, pp. 1131- 1138 ,(2008) , 10.1016/J.ATHORACSUR.2008.05.019
Regine Kluge, Frank Schmidt, Karel Caca, Henryk Barthel, Swen Hesse, Peter Georgi, Anita Seese, Dominik Huster, Frieder Berr, Positron emission tomography with [18F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer Hepatology. ,vol. 33, pp. 1029- 1035 ,(2001) , 10.1053/JHEP.2001.23912